Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers
Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers
Active, not recruiting · NCT03347838 · Registry updated 2025-12-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers | Head and Neck Neoplasms, Neoplasms by Site, neoplasm, precancerous condition | Active, not recruiting | Phase 2 | 2025-12-12 | NCT03347838 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| University of Colorado, Denver | 475 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Denver VA Hospital | Denver | United States | 1 |
| University of Colorado Anschutz Medical Campus | Aurora | United States | 142 |